News & AnalysisNovo Ventures collects $170m for fourth biotech fundNovo Ventures has raised $170 million for its fourth biotech fund.ByIris Dorbian7 January 2021•3 mins readJavaScript is required to read this article. Please enable it in your browser and reload the page.FundraisingFundraisingHealthcareBriefs